Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

PrEP over time: does it change risky behavior?

NCT ID NCT06600087

Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study in France looked at 248 people taking PrEP (a daily pill to prevent HIV) to see how their sexual behaviors and rates of other sexually transmitted infections (STIs) changed over time. Researchers compared those on PrEP for over a year to those on it for less than a year. The goal was to gather information to improve future prevention efforts.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better understand how PrEP affects sexual behavior and STI rates over time, leading to improved prevention strategies.
What could go wrong
This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may not apply to other populations or regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

248 people

The number who actually took part.

Started

Nov 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants on Pre-Exposure Prophylaxis (PrEP) for HIV

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged over 18 years old; * Participants using PrEP for at least 6 months ; * French-speaking, without comprehension disorders ; * being affiliated to health insurance ; * Willing to participate and to sign informed consent. Exclusion Criteria: * Individuals with known HIV positivity;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV infections are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

sexually transmitted disease HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV infections Sexually transmitted diseases

Contacts and locations

Locations

  • CHU de Bordeaux - Service de médecine interne et maladies infectieuses

    Bordeaux, France

  • Cabinet de Medecine Generale

    Fargues-Saint-Hilaire, France

  • Cabinet de Medecine Generale

    Le Teich, France

  • Cabinet de Medecine Generale

    Mérignac, France

  • Cegidd de Bordeaux

    Bordeaux, France

  • Cegidd de Libourne

    Libourne, France

  • Cegidd de Perigueux

    Périgueux, France

  • Maison de la Santé de l'Hôpital Saint-André - Médecine Générale

    Bordeaux, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.